mTOR Signaling: New Insights into Cancer, Cardiovascular Diseases, Diabetes and Aging

Int J Mol Sci. 2023 Sep 4;24(17):13628. doi: 10.3390/ijms241713628.

Abstract

The mechanistic/mammalian target of rapamycin (mTOR), a member of the phosphoinositide 3-kinase (PI3K) related kinase family, integrates intracellular and environmental cues that coordinate a diverse set of cellular/tissue functions, such as cell growth, proliferation, metabolism, autophagy, apoptosis, longevity, protein/lipid/nucleotide synthesis, and tissue regeneration and repair [...].

Publication types

  • Editorial

MeSH terms

  • Cardiovascular Diseases* / etiology
  • Diabetes Mellitus*
  • Humans
  • Neoplasms*
  • Phosphatidylinositol 3-Kinases
  • TOR Serine-Threonine Kinases

Substances

  • Phosphatidylinositol 3-Kinases
  • TOR Serine-Threonine Kinases